Vadlamani S.,Indian National Institute of Pharmaceutical Education and Research
Research Journal of Pharmaceutical, Biological and Chemical Sciences | Year: 2015
Statins are used widely for the treatment of hypercholesterolemia . They inhibit HMG-CoA reductase competitively; reduce LDL levels more than other cholesterol-lowering drugs, and decrease triglyceride levels in hypertriglyceridemic patients. In this review current status of statins, structure and their role and applications is briefly discussed.
Saha S.,Gujarat University |
Goswami G.,Indian National Institute of Pharmaceutical Education and Research
Asian Pacific Journal of Tropical Medicine | Year: 2010
Objective: To investigate the gastroprotective activity of hydroalcoholic extract leaves of Ficus religiosa (F. religiosa) in different experimental models of gastric ulcer in rats. Methods: The hydroalcoholic extract leaves of F. religiosa were studied at two dose levels (250 and 500 mg/kg, oral) in rats against absolute ethanol (0.2 mL oral), aspirin (200 mg/kg) and pyloric ligation induced gastric ulcer. Ranitidine (50 mg/kg, oral) was used as a standard drug. Mean ulcer indices and oxidative stress were measured. Phytochemical tests and acute toxicity tests were also carried out. Results: Administration of F. religiosa to rats significantly decreased the ulcer index value when compared with the control treated group. Ranitidine (50 mg/kg, oral) also produced a significant decrease the ulcer index value when compared with the control treated group. Phytochemical analysis revealed the presence of tannins, sterols, saponins, flavonoids, carbohydrates and proteins. Conclusions: The results suggest that the leaves of the F. religiosa possess significant anti ulcer activity. © 2010 Hainan Medical College.
Dokania S.,Indian National Institute of Pharmaceutical Education and Research |
Joshi A.K.,Indian National Institute of Pharmaceutical Education and Research
Drug Delivery | Year: 2015
Self-microemulsifying drug delivery system (SMEDDS) has emerged as a vital strategy to formulate poor water soluble compounds for bioavailability enhancement. However, certain limitations are associated with SMEDDS formulations which include in vivo drug precipitation, formulation handling issues, limited lymphatic uptake, lack of predictive in vitro tests and oxidation of unsaturated fatty acids. These limitations restrict their potential usage. Inclusion of polymers or precipitation inhibitors within lipid based formulations helps to maintain drug supersaturation after dispersion. This, thereby, improves the bioavailability and reduces the variability on exposure. Also, formulating solid SMEDDS helps to overcome liquid handling and stability problems. Usage of medium chain triglycerides (MCT) and suitable antioxidants to minimize oxidation of unsaturated fatty acids are few of the steps to overcome the limitations associated with SMEDDS. The review discussed here, in detail, the limitations of SMEDDS and suitable measures that can be taken to overcome them. © 2014 Informa Healthcare USA, Inc.
Shah B.,Bv Patel Perd Center |
Khunt D.,Indian National Institute of Pharmaceutical Education and Research |
Bhatt H.,Indian National Institute of Pharmaceutical Education and Research |
Misra M.,Indian National Institute of Pharmaceutical Education and Research |
Padh H.,Sardar Patel University
European Journal of Pharmaceutical Sciences | Year: 2015
In the present investigation, Quality by Design (QbD) approach was applied on the development and optimization of solid lipid nanoparticle (SLN) formulation of hydrophilic drug rivastigmine (RHT). RHT SLN were formulated by homogenization and ultrasonication method using Compritol 888 ATO, tween-80 and poloxamer-188 as lipid, surfactant and stabilizer respectively. The effect of independent variables (X1 - drug: lipid ratio, X2 - surfactant concentration and X3 - homogenization time) on quality attributes of SLN i.e. dependent variables (Y1 - size, Y2 - PDI and Y3 - %entrapment efficiency (%EE)) were investigated using 33 factorial design. Multiple linear regression analysis and ANOVA were employed to indentify and estimate the main effect, 2FI, quadratic and cubic effect. Optimized RHT SLN formula was derived from an overlay plot on which further effect of probe sonication was evaluated. Final RHT SLN showed narrow size distribution (PDI- 0.132 ± 0.016) with particle size of 82.5 ± 4.07 nm and %EE of 66.84 ± 2.49. DSC and XRD study showed incorporation of RHT into imperfect crystal lattice of Compritol 888 ATO. In comparison to RHT solution, RHT SLN showed higher in-vitro and ex-vivo diffusion. The diffusion followed Higuchi model indicating drug diffusion from the lipid matrix due to erosion. Histopathology study showed intact nasal mucosa with RHT SLN indicating safety of RHT SLN for intranasal administration. © 2015 Elsevier B.V. All rights reserved.
Patel N.K.,Indian National Institute of Pharmaceutical Education and Research |
Ramandeep,Indian National Institute of Pharmaceutical Education and Research |
Bhutani K.K.,Indian National Institute of Pharmaceutical Education and Research
Natural Product Communications | Year: 2014
In the continuous search for new antiinflammatory agents from natural products, dichloromethane (DCM), ethyl acetate (EtOAc) and methanol (MeOH) extracts of Ipomea fistulosa leaves were evaluated for inhibition of production of nitric oxide (NO), interleukin 1beta (IL-1β) and tumor necrosis factor alpha (TNF-a) in lipopolysaccharide (LPS) stimulated J774A.1 cells. Among the tested extracts, the ethyl acetate (EtOAc) extract was found to be most active and activity based fractionation of this extract by column chromatography led to the identification of seven compounds for the first time from this plant. Furthermore, 3,4-dimethoxy cinnamic acid (1) exhibited two folds more potent inhibition of LPS-induced NO production (IC50 = 10.7 μg/mL) as compared with the standard, L-NAME (IC50=19.8 μg/mL). The present study supports the use of Ipomea fistulosa leaves for the treatment of inflammation. Copyright © 2014 Natural Product Communciations Inc.